Skip to main content
. Author manuscript; available in PMC: 2018 Jul 3.
Published in final edited form as: Dev Eng. 2017 Jul 3;2:99–106. doi: 10.1016/j.deveng.2017.06.002

Table 3.

Costs, DALYs averted and incremental cost effectiveness ratios (ICER) for devices used to detect pre-eclampsia.

Device Total cost
of
intervention		 Incremental
cost		 DALYs Incremental
effectiveness
(DALYs
averted)		 ICER (cost per
DALY gained)
Baseline (no screening) 0.080 0.05137
Microlife, Uristik 0.305 0.2243 0.04898 0.00240 94
Nissei (low), Uristik 0.322 0.0174 0.04896 0.00002 829
Nissei (high), Uristik 0.339 0.0173 0.04896 0.00000 *
Sphygmo (low), Uristik 0.369 0.0467 0.04883 0.00013 368
Sphygmo (high), Uristik 0.384 0.0153 0.04883 0.00000 *
Microlife, Multistix 0.452 0.0828 0.05045 −0.00162 *
Sphygmo (low), Multistix 0.457 0.0883 0.05039 −0.00156 *
Nissei (low), Multistix 0.458 0.0895 0.05044 −0.00161 *
Nissei (high), Multistix 0.476 0.1068 0.05044 −0.00161 *
Spot Vital Signs (low), Uristik 0.481 0.1123 0.04892 −0.00009 *
Spot Vital Signs (high), Uristik 0.553 0.1837 0.04892 −0.00009 *
Sphygmo (high), Multistix 0.567 0.1981 0.05039 −0.00156 *
Spot Vital Signs (low), Multistix 0.686 0.3171 0.05042 −0.00160 *
Nissei (low), CLINITEK(low) 0.716 0.3472 0.04798 0.00085 408
Nissei (low), CLINITEK(high) 0.724 0.0084 0.04798 0.00000 *
Microlife, CLINITEK(low) 0.731 0.0150 0.04801 −0.00003 *
Nissei (high), CLINITEK(low) 0.733 0.0173 0.04798 0.00000 *
Nissei (high), CLINITEK(high) 0.742 0.0257 0.04798 0.00000 *
Spot Vital Signs (high), Multistix 0.757 0.0413 0.05042 −0.00245 *
Microlife, CLINITEK 0.758 0.0418 0.04801 −0.00003 *
Sphygmo (low), CLINITEK(low) 0.903 0.1867 0.04780 0.00018 1055
Sphygmo (low), CLINITEK(high) 0.914 0.0112 0.04780 0.00000 *
Sphygmo (high), CLINITEK(low) 0.918 0.0153 0.04780 0.00000 *
Sphygmo (high), CLINITEK(high) 0.929 0.0265 0.04780 0.00000 *
Nissei (low), DCA 2000+ 0.948 0.0453 0.04784 −0.00004 *
Nissei (high), DCA 2000+ 0.965 0.0627 0.04784 −0.00004 *
Microlife, DCA 2000+ 0.976 0.0738 0.04787 −0.00007 *
Spot Vital Signs (low), CLINITEK(low) 1.082 0.1792 0.04793 −0.00013 *
Spot Vital Signs (low), CLINITEK(high) 1.094 0.1917 0.04793 −0.00013 *
Spot Vital Signs (high), CLINITEK(low) 1.153 0.2506 0.04793 −0.00013 *
Spot Vital Signs (high), CLINITEK(high) 1.166 0.2631 0.04793 −0.00013 *
Sphygmo (low), DCA 2000+ 1.199 0.2959 0.04765 0.00015 2026
Sphygmo (high), DCA 2000+ 1.214 0.0153 0.04765 0.00000 *
Spot Vital Signs (low), DCA 2000+ 1.404 0.2057 0.04779 −0.00013 *
Spot Vital Signs (high), DCA 2000+ 1.476 0.2771 0.04779 −0.00013 *

Notes: Costs in US 2015 dollars. ICERs from decision tree simulation where testing rate is not 100%. Devices ordered by cost of intervention. Effectiveness calculated relative to scenario with no pre-eclampsia. Baseline scenario has no access to diagnostic testing or clinical management (see text).

Asterisk (*) indicates that ICER is not applicable due to dominance by prior strategy. These rows are skipped in calculating incremental costs and effectiveness in subsequent rows.

Italics indicates extended dominance; see text.